Effects of transforming growth factor beta1 (TGFbeta-1) and dentin non-collagenous proteins (DNCP) on human embryonic ectomesenchymal cells in a three-dimensional culture system.
Cranial neural crest-derived ectomesenchymal cells represent a population of pluripotent stem cells giving rise to many of the various oro-facial and dental tissues. The factors determining the terminal fate of these cells are still unclear. The potentiality of human embryonic ectomesenchymal cells from the first branchial arch have been investigated when isolated and grown in a three-dimensional (3D)-collagen gel culture system in the presence of dentin matrix-derived non-collagenous proteins (DNCP) and TGFbeta-1. Functional differentiation of cells showing some characteristics of odontoblast-like cells could be observed when the cells were cultured with DNCP+TGFbeta-1 or DNCP, however, only cytological differentiation was observed during culture with TGFbeta-1 alone. The characteristics of these cells was assessed by morphological appearance, expression of the odontoblast phenotype marker dentin sialophosphoprotein (DSPP), increased alkaline phosphatase levels and formation of mineralised nodules in vitro. The results indicate that these embryonic cells from the first branchial arch are capable of responding to the inductive stimulus of DNCP or DNCP+TGFbeta-1 when isolated and grown in the 3D collagen gel culture system. The capacity of the isolated cells to differentiate into mineralizing cells showing some characteristics of odontoblast-like cells under these growth conditions highlights the potential of such approaches for tissue engineering strategies for hard-tissue regeneration after injury.
Deng
Manjing
M
Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, Shaanxi 710032, PR China.
Shi
Junnan
J
Smith
Anthony J
AJ
Jin
Yan
Y
D000469:Alkaline Phosphatase / Q000378:metabolism; D002478:Cells, Cultured; D003810:Dentinogenesis / Q000187:drug effects*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008648:Mesoderm / Q000166:cytology*; D009055:Mouth / Q000196:embryology*; D010750:Phosphoproteins / Q000494:pharmacology*; D039904:Pluripotent Stem Cells / Q000166:cytology* / Q000187:drug effects; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013194:Staining and Labeling; D023822:Tissue Engineering; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
D010750:Phosphoproteins; D016212:Transforming Growth Factor beta; C017630:phosphophoryn; D000469:Alkaline Phosphatase